<DOC>
	<DOCNO>NCT00002182</DOCNO>
	<brief_summary>The purpose study see megestrol acetate safe effective treat HIV-infected child failure thrive ( FTT ) .</brief_summary>
	<brief_title>A Study Megestrol Acetate HIV-Infected Children</brief_title>
	<detailed_description>The study design randomize , double-blind , placebo-controlled 12 week open-label drug offer week 12 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Failure Thrive</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Inclusion Criteria Patients must : Documented HIV infection . Failure thrive define : cross 2 percentile line standard weight age curve time le 5 % percentile weight age fall curve loss 10 % baseline body weight . Resistant oral nutritional supplementation ( i.e. , FTT despite minimum 1month trial highcalorie oral supplement ) . Free significant acute illness ( mild upper respiratory tract infection allow ) . Patients chronic diarrhea allow provided malabsorption gastrointestinal infection rule . Exclusion Criteria Coexisting Condition : Patients follow symptom exclude : Gastrointestinal infection malabsorption . Significant acute illness . Any identified , untreated cause failure thrive underlying HIV infection . Medical contraindication megestrol acetate . Patients follow prior condition symptom exclude : Medical contraindication megestrol acetate include history poorlycontrolled hypertension , deep venous thrombosis , heart failure . History prior megestrol acetate therapy past six month .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 1998</verification_date>
	<keyword>Placebos</keyword>
	<keyword>Appetite Stimulants</keyword>
	<keyword>Megestrol Acetate</keyword>
	<keyword>Failure Thrive</keyword>
</DOC>